Joan B. Gornals , Albert Sumalla-Garcia , Daniel Luna-Rodriguez , Maria Puigcerver-Mas , Julio G. Velasquez-Rodriguez , Silvia Salord , Sandra Maisterra , Juli Busquets
{"title":"Long-term outcomes of endoscopic ultrasound-guided pancreatic duct interventions: A single tertiary center experience","authors":"Joan B. Gornals , Albert Sumalla-Garcia , Daniel Luna-Rodriguez , Maria Puigcerver-Mas , Julio G. Velasquez-Rodriguez , Silvia Salord , Sandra Maisterra , Juli Busquets","doi":"10.1016/j.gastre.2024.502221","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and aims</h3><div>Endoscopic ultrasound-guided pancreatic duct intervention (EUS-PDI) is one of the most technically challenging procedures. There remains a knowledge gap due to its rarity. The aim is to report the accumulated EUS-PDI experience in a tertiary center.</div></div><div><h3>Methods</h3><div>Single tertiary center, retrospective cohort study of prospectively collected data during the study period, from January 2013 to June 2021.</div></div><div><h3>Results</h3><div>In total, 14 patients (85% male; mean age, 61 years, range 37–81) and 25 EUS-PDI procedures for unsuccessful endoscopic retrograde pancreatography (ERP) were included. Principal etiology was chronic pancreatitis with pancreatic duct obstruction (78%). EUS-guided assisted (colorant and/or guidewire, <em>rendezvous</em>) ERP was performed in 14/25 (56%); and transmural drainage in 11 procedures, including pancreaticogastrosmy in 9/25 (36%) and pancreaticoduodenostomy in 2/25 (8%). Overall technical and clinical success was 78.5% (11/14). Three (21%) patients required a second procedure with success in all cases. Two failed cases required surgery. Three (21%) adverse events (AEs) were noted (fever, <em>n</em> <!-->=<!--> <!-->1; perforation, <em>n</em> <!-->=<!--> <!-->1; pancreatitis, <em>n</em> <!-->=<!--> <!-->1). Patients underwent a median of 58 months (range 24–108) follow-up procedures for re-stenting. Spontaneous stent migration was detected in 50% of cases.</div></div><div><h3>Conclusions</h3><div>EUS-PDI is an effective salvage therapy for unsuccessful ERP, although 21% of patients may still experience AEs. In case of EUS-guided <em>rendezvous</em> failure, it can cross over to a transmural drainage.</div></div>","PeriodicalId":100569,"journal":{"name":"Gastroenterología y Hepatología (English Edition)","volume":"48 2","pages":"Article 502221"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterología y Hepatología (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2444382424002669","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims
Endoscopic ultrasound-guided pancreatic duct intervention (EUS-PDI) is one of the most technically challenging procedures. There remains a knowledge gap due to its rarity. The aim is to report the accumulated EUS-PDI experience in a tertiary center.
Methods
Single tertiary center, retrospective cohort study of prospectively collected data during the study period, from January 2013 to June 2021.
Results
In total, 14 patients (85% male; mean age, 61 years, range 37–81) and 25 EUS-PDI procedures for unsuccessful endoscopic retrograde pancreatography (ERP) were included. Principal etiology was chronic pancreatitis with pancreatic duct obstruction (78%). EUS-guided assisted (colorant and/or guidewire, rendezvous) ERP was performed in 14/25 (56%); and transmural drainage in 11 procedures, including pancreaticogastrosmy in 9/25 (36%) and pancreaticoduodenostomy in 2/25 (8%). Overall technical and clinical success was 78.5% (11/14). Three (21%) patients required a second procedure with success in all cases. Two failed cases required surgery. Three (21%) adverse events (AEs) were noted (fever, n = 1; perforation, n = 1; pancreatitis, n = 1). Patients underwent a median of 58 months (range 24–108) follow-up procedures for re-stenting. Spontaneous stent migration was detected in 50% of cases.
Conclusions
EUS-PDI is an effective salvage therapy for unsuccessful ERP, although 21% of patients may still experience AEs. In case of EUS-guided rendezvous failure, it can cross over to a transmural drainage.